非感染性黄斑浮腫治療の世界市場 2019年版：種類別（抗VEGF療法、コルチコステロイド、免疫抑制剤、生物学的製剤、その他）、用途別（小売薬局、病院薬局、その他）

• 英文タイトル：Global Non-infectious Macular Edema Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：C-GIR20G2900
• 出版社/出版日：GlobalInfoResearch / 2019年12月30日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、102ページ
• 納品方法：Eメール
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

「非感染性黄斑浮腫治療の世界市場2019年」は、グローバルにおける非感染性黄斑浮腫治療市場を展望するレポートです。非感染性黄斑浮腫治療のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。
・非感染性黄斑浮腫治療の市場概観
・非感染性黄斑浮腫治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・非感染性黄斑浮腫治療の企業別販売動向、市場シェア、市場集中度、競争動向
・非感染性黄斑浮腫治療の世界市場規模
・非感染性黄斑浮腫治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・非感染性黄斑浮腫治療のアメリカ市場規模推移
・非感染性黄斑浮腫治療のカナダ市場規模推移
・非感染性黄斑浮腫治療のメキシコ市場規模推移
・非感染性黄斑浮腫治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・非感染性黄斑浮腫治療のドイツ市場規模推移
・非感染性黄斑浮腫治療のイギリス市場規模推移
・非感染性黄斑浮腫治療のロシア市場規模推移
・非感染性黄斑浮腫治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・非感染性黄斑浮腫治療の日本市場規模推移
・非感染性黄斑浮腫治療の中国市場規模推移
・非感染性黄斑浮腫治療の韓国市場規模推移
・非感染性黄斑浮腫治療のインド市場規模推移
・非感染性黄斑浮腫治療の東南アジア市場規模推移
・非感染性黄斑浮腫治療の南米市場分析（ブラジル、アルゼンチン等）
・非感染性黄斑浮腫治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・非感染性黄斑浮腫治療の種類別分析/販売量、売上、市場シェア（抗VEGF療法、コルチコステロイド、免疫抑制剤、生物学的製剤、その他）
・非感染性黄斑浮腫治療の用途別分析/市場規模（小売薬局、病院薬局、その他）
・非感染性黄斑浮腫治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・非感染性黄斑浮腫治療の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Non-infectious Macular Edema Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-infectious Macular Edema Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Non-infectious Macular Edema Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-infectious Macular Edema Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Bayer AG
Valeant Pharmaceuticals
Novartis AG
Amgen
Allergan
Pfizer
Clearside Biomedical
AbbVie
F. Hoffman-La Roche
Alimera Sciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Anti-VEGF Therapy
Corticosteroid
Immune Inhibitor
Biological Preparation
Other

Market Segment by Applications, can be divided into
Retail Pharmacy
Hospital Pharmacy
Other

レポート目次

Table of Contents

1 Non-infectious Macular Edema Treatment Market Overview
1.1 Product Overview and Scope of Non-infectious Macular Edema Treatment
1.2 Classification of Non-infectious Macular Edema Treatment by Types
1.2.1 Global Non-infectious Macular Edema Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Non-infectious Macular Edema Treatment Revenue Market Share by Types in 2018
1.2.3 Anti-VEGF Therapy
1.2.4 Corticosteroid
1.2.5 Immune Inhibitor
1.2.6 Biological Preparation
1.2.7 Other
1.3 Global Non-infectious Macular Edema Treatment Market by Application
1.3.1 Global Non-infectious Macular Edema Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Non-infectious Macular Edema Treatment Market by Regions
1.4.1 Global Non-infectious Macular Edema Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Non-infectious Macular Edema Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-infectious Macular Edema Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-infectious Macular Edema Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Non-infectious Macular Edema Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-infectious Macular Edema Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Non-infectious Macular Edema Treatment (2014-2024)
2 Company Profiles
2.1 Bayer AG
2.1.1 Business Overview
2.1.2 Non-infectious Macular Edema Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer AG Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Valeant Pharmaceuticals
2.2.1 Business Overview
2.2.2 Non-infectious Macular Edema Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis AG
2.3.1 Business Overview
2.3.2 Non-infectious Macular Edema Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis AG Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Non-infectious Macular Edema Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Allergan
2.5.1 Business Overview
2.5.2 Non-infectious Macular Edema Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Allergan Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Non-infectious Macular Edema Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Clearside Biomedical
2.7.1 Business Overview
2.7.2 Non-infectious Macular Edema Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Clearside Biomedical Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 AbbVie
2.8.1 Business Overview
2.8.2 Non-infectious Macular Edema Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AbbVie Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 F. Hoffman-La Roche
2.9.1 Business Overview
2.9.2 Non-infectious Macular Edema Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 F. Hoffman-La Roche Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Alimera Sciences
2.10.1 Business Overview
2.10.2 Non-infectious Macular Edema Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Alimera Sciences Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Non-infectious Macular Edema Treatment Market Competition, by Players
3.1 Global Non-infectious Macular Edema Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-infectious Macular Edema Treatment Players Market Share
3.2.2 Top 10 Non-infectious Macular Edema Treatment Players Market Share
3.3 Market Competition Trend
4 Global Non-infectious Macular Edema Treatment Market Size by Regions
4.1 Global Non-infectious Macular Edema Treatment Revenue and Market Share by Regions
4.2 North America Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
5 North America Non-infectious Macular Edema Treatment Revenue by Countries
5.1 North America Non-infectious Macular Edema Treatment Revenue by Countries (2014-2019)
5.2 USA Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
6 Europe Non-infectious Macular Edema Treatment Revenue by Countries
6.1 Europe Non-infectious Macular Edema Treatment Revenue by Countries (2014-2019)
6.2 Germany Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
6.4 France Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Non-infectious Macular Edema Treatment Revenue by Countries
7.1 Asia-Pacific Non-infectious Macular Edema Treatment Revenue by Countries (2014-2019)
7.2 China Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
7.5 India Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
8 South America Non-infectious Macular Edema Treatment Revenue by Countries
8.1 South America Non-infectious Macular Edema Treatment Revenue by Countries (2014-2019)
8.2 Brazil Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Non-infectious Macular Edema Treatment by Countries
9.1 Middle East and Africa Non-infectious Macular Edema Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
10 Global Non-infectious Macular Edema Treatment Market Segment by Type
10.1 Global Non-infectious Macular Edema Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Non-infectious Macular Edema Treatment Market Forecast by Type (2019-2024)
10.3 Anti-VEGF Therapy Revenue Growth Rate (2014-2024)
10.4 Corticosteroid Revenue Growth Rate (2014-2024)
10.5 Immune Inhibitor Revenue Growth Rate (2014-2024)
10.6 Biological Preparation Revenue Growth Rate (2014-2024)
10.7 Other Revenue Growth Rate (2014-2024)
11 Global Non-infectious Macular Edema Treatment Market Segment by Application
11.1 Global Non-infectious Macular Edema Treatment Revenue Market Share by Application (2014-2019)
11.2 Non-infectious Macular Edema Treatment Market Forecast by Application (2019-2024)
11.3 Retail Pharmacy Revenue Growth (2014-2019)
11.4 Hospital Pharmacy Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Non-infectious Macular Edema Treatment Market Size Forecast (2019-2024)
12.1 Global Non-infectious Macular Edema Treatment Market Size Forecast (2019-2024)
12.2 Global Non-infectious Macular Edema Treatment Market Forecast by Regions (2019-2024)
12.3 North America Non-infectious Macular Edema Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Non-infectious Macular Edema Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Non-infectious Macular Edema Treatment Revenue Market Forecast (2019-2024)
12.6 South America Non-infectious Macular Edema Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Non-infectious Macular Edema Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Non-infectious Macular Edema Treatment Picture
Table Product Specifications of Non-infectious Macular Edema Treatment
Table Global Non-infectious Macular Edema Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Non-infectious Macular Edema Treatment Revenue Market Share by Types in 2018
Figure Anti-VEGF Therapy Picture
Figure Corticosteroid Picture
Figure Immune Inhibitor Picture
Figure Biological Preparation Picture
Figure Other Picture
Table Global Non-infectious Macular Edema Treatment Revenue (Million USD) by Application (2014-2024)
Figure Non-infectious Macular Edema Treatment Revenue Market Share by Applications in 2018
Figure Retail Pharmacy Picture
Figure Hospital Pharmacy Picture
Figure Other Picture
Table Global Market Non-infectious Macular Edema Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Non-infectious Macular Edema Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Non-infectious Macular Edema Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Non-infectious Macular Edema Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Non-infectious Macular Edema Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Non-infectious Macular Edema Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Non-infectious Macular Edema Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Bayer AG Basic Information, Manufacturing Base and Competitors
Table Bayer AG Non-infectious Macular Edema Treatment Type and Applications
Table Bayer AG Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Type and Applications
Table Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Non-infectious Macular Edema Treatment Type and Applications
Table Novartis AG Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Non-infectious Macular Edema Treatment Type and Applications
Table Amgen Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Non-infectious Macular Edema Treatment Type and Applications
Table Allergan Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Non-infectious Macular Edema Treatment Type and Applications
Table Pfizer Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Clearside Biomedical Basic Information, Manufacturing Base and Competitors
Table Clearside Biomedical Non-infectious Macular Edema Treatment Type and Applications
Table Clearside Biomedical Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Non-infectious Macular Edema Treatment Type and Applications
Table AbbVie Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffman-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffman-La Roche Non-infectious Macular Edema Treatment Type and Applications
Table F. Hoffman-La Roche Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Alimera Sciences Basic Information, Manufacturing Base and Competitors
Table Alimera Sciences Non-infectious Macular Edema Treatment Type and Applications
Table Alimera Sciences Non-infectious Macular Edema Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Non-infectious Macular Edema Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Non-infectious Macular Edema Treatment Revenue Share by Players (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Revenue Share by Players in 2017
Figure Global Non-infectious Macular Edema Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Non-infectious Macular Edema Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Non-infectious Macular Edema Treatment Revenue Market Share in 2018
Figure Global Non-infectious Macular Edema Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Non-infectious Macular Edema Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Non-infectious Macular Edema Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Revenue Market Share by Regions in 2018
Figure North America Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure South America Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Table North America Non-infectious Macular Edema Treatment Revenue by Countries (2014-2019)
Table North America Non-infectious Macular Edema Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Non-infectious Macular Edema Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Non-infectious Macular Edema Treatment Revenue Market Share by Countries in 2018
Figure USA Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Table Europe Non-infectious Macular Edema Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Non-infectious Macular Edema Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Non-infectious Macular Edema Treatment Revenue Market Share by Countries in 2018
Figure Germany Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure UK Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure France Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Non-infectious Macular Edema Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Non-infectious Macular Edema Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Non-infectious Macular Edema Treatment Revenue Market Share by Countries in 2018
Figure China Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure India Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Table South America Non-infectious Macular Edema Treatment Revenue by Countries (2014-2019)
Table South America Non-infectious Macular Edema Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Non-infectious Macular Edema Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Non-infectious Macular Edema Treatment Revenue Market Share by Countries in 2018
Figure Brazil Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Non-infectious Macular Edema Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Non-infectious Macular Edema Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-infectious Macular Edema Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-infectious Macular Edema Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Non-infectious Macular Edema Treatment Revenue and Growth Rate (2014-2019)
Table Global Non-infectious Macular Edema Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Non-infectious Macular Edema Treatment Revenue Share by Type (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Revenue Share by Type (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Revenue Share by Type in 2018
Table Global Non-infectious Macular Edema Treatment Revenue Forecast by Type (2019-2024)
Figure Global Non-infectious Macular Edema Treatment Market Share Forecast by Type (2019-2024)
Figure Global Anti-VEGF Therapy Revenue Growth Rate (2014-2019)
Figure Global Corticosteroid Revenue Growth Rate (2014-2019)
Figure Global Immune Inhibitor Revenue Growth Rate (2014-2019)
Figure Global Biological Preparation Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Non-infectious Macular Edema Treatment Revenue by Application (2014-2019)
Table Global Non-infectious Macular Edema Treatment Revenue Share by Application (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Revenue Share by Application (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Revenue Share by Application in 2018
Table Global Non-infectious Macular Edema Treatment Revenue Forecast by Application (2019-2024)
Figure Global Non-infectious Macular Edema Treatment Market Share Forecast by Application (2019-2024)
Figure Global Retail Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Hospital Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Non-infectious Macular Edema Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Non-infectious Macular Edema Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Non-infectious Macular Edema Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Non-infectious Macular Edema Treatment Revenue Market Forecast (2019-2024)
Figure Europe Non-infectious Macular Edema Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Non-infectious Macular Edema Treatment Revenue Market Forecast (2019-2024)
Figure South America Non-infectious Macular Edema Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Non-infectious Macular Edema Treatment Revenue Market Forecast (2019-2024)

Global Cutaneous Fribrosis Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
C-GIR20G0535 2019年12月30日 100Pages
「皮膚線維症治療の世界市場2019年」は、グローバルにおける皮膚線維症治療市場を展望するレポートです。皮膚線維症治療のグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ...

皮膚線維症治療の世界市場 2019年版：種類別（免疫療法、コルチコステロイド、抗線維化薬、免疫グロブリン）、用途別（病院薬局、小売薬局、オンライン薬局）

Global Cutaneous Fibrosis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
C-GIR20G2626 2019年12月30日 102Pages
「皮膚線維症治療の世界市場2019年」は、グローバルにおける皮膚線維症治療市場を展望するレポートです。皮膚線維症治療のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）デー...

多発性筋炎治療の世界市場 2019年版：種類別（免疫抑制剤、アルキル化剤、免疫グロブリン、モノクローナル抗体、コルチコステロイド）、用途別（病院、クリニック、その他）

Global Polymyositis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
C-GIR20G2954 2019年12月30日 102Pages
「多発性筋炎治療の世界市場2019年」は、グローバルにおける多発性筋炎治療市場を展望するレポートです。多発性筋炎治療のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）デー...

貧血治療薬の世界市場 2019年版：種類別（サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤）、用途別（鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌状赤血球貧血、悪性貧血）

Global Anemia Treatment Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
C-GIR20G2490 2019年12月30日 100Pages
「貧血治療薬の世界市場2019年」は、グローバルにおける貧血治療薬市場を展望するレポートです。貧血治療薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載...

クリプトコッカス症治療の世界市場 2019年版：種類別（アムホテリシンB、フルシトシン、フルコナゾール）、用途別（病院薬局、小売薬局、ドラッグストア、その他）

Global Cryptococcosis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
C-GIR20G2623 2019年12月30日 106Pages
「クリプトコッカス症治療の世界市場2019年」は、グローバルにおけるクリプトコッカス症治療市場を展望するレポートです。クリプトコッカス症治療のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本...

アジスロマイシンの世界市場 2019年版：種類別（経口剤、注射剤、眼科）、用途別（病院薬局、小売薬局、オンライン薬局）

Global Azithromycin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
C-GIR20G0192 2019年12月30日 107Pages
「アジスロマイシンの世界市場2019年」は、グローバルにおけるアジスロマイシン市場を展望するレポートです。アジスロマイシンのグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、ア...

エタンシレートの世界市場 2019年版：種類別（錠剤、注射）、用途別（病院薬局、小売薬局、オンライン薬局）

Global Etamsylate (Ethamsylate) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
C-GIR20G0728 2019年12月30日 102Pages
「エタンシレートの世界市場2019年」は、グローバルにおけるエタンシレート市場を展望するレポートです。エタンシレートのグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ...

ダブルチャンバープレフィルドシリンジの世界市場 2019年版：種類別（<1.0 mL、1.0 – 2.5 mL、2.5 – 5.0 mL、> 5 mL）、用途別（病院薬局、小売薬局、オンライン薬局）

Global Double Chamber Prefilled Syringe Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
C-GIR20G0613 2019年12月30日 106Pages
「ダブルチャンバープレフィルドシリンジの世界市場2019年」は、グローバルにおけるダブルチャンバープレフィルドシリンジ市場を展望するレポートです。ダブルチャンバープレフィルドシリンジのグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分...

小児用電解質溶液の世界市場 2019年版：種類別（経口、注射）、用途別（病院薬局、小売薬局、オンライン薬局）

Global Pediatric Electrolyte Solutions Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
C-GIR20G1602 2019年12月30日 103Pages
「小児用電解質溶液の世界市場2019年」は、グローバルにおける小児用電解質溶液市場を展望するレポートです。小児用電解質溶液のグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、ア...

メスナ（メスネックス）の世界市場 2019年版：種類別（経口、注射）、用途別（病院薬局、小売薬局、オンライン薬局）

Global Mesna (Mesnex) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
C-GIR20G1349 2019年12月30日 108Pages
「メスナ（メスネックス）の世界市場2019年」は、グローバルにおけるメスナ（メスネックス）市場を展望するレポートです。メスナ（メスネックス）のグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分...

世界の黄斑変性症治療市場予測（～2024年） Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that m…
世界の肺水腫治療市場予測（～2024年） Pulmonary edema refers to the generation and reflux imbalance of tissue fluid in the lung caused by some reasons, so that a large number of tissue fluid in a very short period of time can not be absorbed by the pulmonary lymphatic and pulmonary vein system, from the pulmonary capillary osmosis, accu…
浮腫臨床試験の世界市場 2019年版：種類別（全身、ローカル）、用途別（病院、医学研究機関、その他） Scope of the Report: The global Edema Clinical Trials market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, als…
膀胱浮腫臨床試験の世界市場 2019年版：種類別（トラクション糖尿病、糖尿病網膜症、嚢胞）、用途別（病院、医学研究機関、その他） Scope of the Report: The global Cystoid Edema Clinical Trials market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Ch…
世界のIVD感染症市場予測（～2024年） In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease. Scope of the Report: The global IVD Infectiou…